PYOPEN Drug Patent Profile
When do Pyopen patents expire, and what generic alternatives are available?
Pyopen is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in PYOPEN is carbenicillin disodium. There is one drug master file entry for this compound. Additional details are available on the carbenicillin disodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PYOPEN?
- What are the global sales for PYOPEN?
- What is Average Wholesale Price for PYOPEN?
Summary for PYOPEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 30 |
| Patent Applications: | 4,888 |
| DailyMed Link: | PYOPEN at DailyMed |
US Patents and Regulatory Information for PYOPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | PYOPEN | carbenicillin disodium | INJECTABLE;INJECTION | 050298-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | PYOPEN | carbenicillin disodium | INJECTABLE;INJECTION | 050298-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | PYOPEN | carbenicillin disodium | INJECTABLE;INJECTION | 050298-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | PYOPEN | carbenicillin disodium | INJECTABLE;INJECTION | 050298-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | PYOPEN | carbenicillin disodium | INJECTABLE;INJECTION | 050298-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
